What is Lee Silsby Compounding Pharmacy?
Lee Silsby Compounding Pharmacy operates at the intersection of personalized medicine and clinical excellence. By focusing on innovative compounded medications, the company addresses specific health requirements that standard pharmaceutical offerings often overlook. Their core competency lies in the development of supplements and tailored treatments designed to optimize nutrient absorption and support both physical and cognitive health. Through a robust service model that bridges the gap between healthcare providers and patients, the pharmacy has established itself as a critical player in the wellness sector, prioritizing precision and efficacy in every formulation.
How much funding has Lee Silsby Compounding Pharmacy raised?
Lee Silsby Compounding Pharmacy has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Lee Silsby Compounding Pharmacy
PPP
Public-Private Partnership
What's next for Lee Silsby Compounding Pharmacy?
Following this late-stage financing, Lee Silsby Compounding Pharmacy is poised to accelerate its market expansion and enhance its technological infrastructure. The strategic deployment of these funds will likely focus on scaling production capabilities to meet rising demand for personalized health interventions. By leveraging this financial backing, the company aims to deepen its research into cognitive health supplements and broaden its reach within the healthcare provider network. As the firm transitions into this next phase of growth, the focus remains on maintaining the high standards of customer service and clinical precision that have defined its reputation in the compounding industry.
See full Lee Silsby Compounding Pharmacy company page
